Page last updated: 2024-09-05

organophosphonates and Cerebrovascular Disorders

organophosphonates has been researched along with Cerebrovascular Disorders in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dirnagl, U; Huth, A; Jacobsen, P; McDonald, F; Neuhaus, R; Ottow, E; Schneider, HH; Sheardown, M; Turski, L; Wiegand, F1
Fischer, KC; McKusick, KA; Pendergrass, HP; Potsain, MS1

Other Studies

2 other study(ies) available for organophosphonates and Cerebrovascular Disorders

ArticleYear
ZK200775: a phosphonate quinoxalinedione AMPA antagonist for neuroprotection in stroke and trauma.
    Proceedings of the National Academy of Sciences of the United States of America, 1998, Sep-01, Volume: 95, Issue:18

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Cells, Cultured; Cerebrovascular Disorders; Craniocerebral Trauma; Evoked Potentials; Excitatory Amino Acid Antagonists; Gerbillinae; In Vitro Techniques; Mice; Neuroprotective Agents; Organophosphonates; Quinoxalines; Radioligand Assay; Rats

1998
Improved brain scan specificity utilizing 99mTc-pertechnetate and 99mTc(Sn)-diphosphonate.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1975, Volume: 16, Issue:8

    Topics: Adult; Aged; Astrocytoma; Brain; Brain Abscess; Brain Diseases; Brain Neoplasms; Cerebrovascular Disorders; Female; Hematoma, Subdural; Humans; Male; Middle Aged; Organophosphonates; Radionuclide Imaging; Technetium

1975